INO Inovio Pharmaceuticals Inc

$INO I was inspired by and several of you guys to buy some more today. My spacesuit is looking shiny and ready for lift off.

$INO We Know INOVIO Won The VGXI Case With $80,000,000 In Damages.....INOVIO's DNA Plasmid Technology Is Secure....INOVIO Is Free To Pursue Partnerships With $$$$ Upfront From Big Pharma All Along Their Pipeline.... Next VGX 3100 Gets Approval In Asia....Massive Milestone Payments Along With Royalties Estimated At $100,000,000 - $200,000,000 Annually....In Addition INOVIO Will Receive Approval For INO 3107.....Because INO 3107 Requires Zero Mid Dosing Surgery....Along With The Complete Response At 50% In The 2nd Year Of Dosing.....With 54% Of Patients Experiencing Complete Response Going Into The 3rd Year.....In Parallel Precigen's Complete Response Is Receding To 43% From 50%.....I Believe All Of This Will Happen Over The Next 30 To 60 Days.....I Also Feel This Stock Will Be Like Owning Apple....Tesla..... Regeneron In The First Inning.....I Have Close To 100,000 Shares Right Now.....None For Sale....I See A $20-$30 Stock In 9 To 12 Months Easily.... From There $100 in a couple Of Years

$INO I look at it this way: What has changed since yesterday? We won a lawsuit worth $80.4M. Whether we can collect it all remains to be seen, but the company says it will make every reasonable effort to recover the money. So what exactly justifies being in the red? Nothing fundamental has changed. Shorts are doing everything they can to suppress a major move, but how long can that last? With the FDA decision on INO-3107 approaching, this week or next, they may soon have a much bigger problem to deal with. 🔥🚀

$INO The Stars Are Aligning Also With VGX 3100 Heading For Approval In China.....The Partnership With ApolloBio Includes Big Milestone $$$$$ Payments Along With Royalties That Should Far Exceed $100,000,000 A Year....The Asian Market In The Agreement Includes China....Hong Kong....Macau....Taiwan....Eventually South Korea....INOVIO's INO 3107 Treats/Cures Cervical Dysplasia Brought On By HPV.....The Market In Asia Is Huge.....The Results Have Been Superb With All The Media Coverage Pointing To A Rapid Approval In 2026.....THREE IMPORTANT POSTIVE DEVELOPMENTS COMING TO FRUITION IN 2026.....VGXI CASE WON BY INOVIO....INO 3107 APPROVAL ANY DAY NOW....A BIG GREEN LIGHT FOR VGX 3100 IN ASIA.....A MASSIVE TURNAROUND AND VINDICATION FOR SHAREHOLDERS IS ON THE WAY I BELIEVE!!!!!!!!!

$INO Been forever since i posted. watched from the sidelines holding like everyone else. If 3107 receives approval from the FDA, I wonder if that will reignite a potential BO. I always thought thats where this was heading. First wrap up the lawsuit (done), get first product over the finishline (pending) which would validate DNA medicine, and then…. I guess we’ll see. Not to much longer until we know at least. GLTA

$INO More than 4 decades of DNA and CELLECTRA research has brought us to this moment. History is about to be made with INO-3107 being their very first FDA approved DNA therapeutic.

$INO This movement makes no sense, inovio has won a court battle, that if vgxi had been in his place we would probably have made peaks like moderna and instead they make it go down? Is someone raking in as many shares as he can take at a good price? Such a descent makes no sense

$INO Tomorrow will be a day to remember for the shorts! Heavy volume will pour in! wouldn't be surprised if we open up 25%-50% and continue up from there. Shorty going to learn a good lesson!🚀🚀🚀

$INO Moderna stealing the show today, i called it... THEY ONLY SAY THEY HAVE THE CURE FOR CANCER WHEN INOVIO DATA CAN NO LONGER BE BLOCKED... I knew our news would be great because all the hype $MRNA was trying to create... Inovio/ Geneos are the only companies with the ability to make personalized cancer vaccines. 30th can't come fast enough 🧬🧬🧬🌍🌏🌎 Like Ben said. DNA IS GREATER THAN RNA

$INO People mentioned leaks here. I don't think there is a leak just a pull back for playing it safe before the big decision, protection. The communication FDA is sent electronically through the FDA Electronic Submissions Gateway (ESG), not via standard email or a physical mailed letter. 30th is the action date but it could be released to INO early so hold on to your self because it's either early release this Friday or next Friday as planned.If a LEAK was engaged some serious consequences and SEC involvement would be actioned. The money through the legal matter. Is just a added kind of yes we won but oh we might not recover it all. Combo with how the Market is at present along with uncertainty and the legal case win. Bullish, think positive probibility 75 percent. FDA acceptance.

$INO Understand What Winning The VGXI Case Means To INOVIO.....Any Partnerships With Upfront $$$$$ Are Free To Move Forward Without Hesitancy....Shareholders I Believe Will See Multiple Deals Roll Out Along INOVIO's Pipeline.....In Addition INOVIO Is Awarded $80,000,000 In Damages....This Is A Major Validation Of INOVIO's Ownership Of Their Technology.....For INOVIO This Is A Big Moment To Celebrate And Great For The Future Of The Company!!!!!!!

$INO for the bulls the bottom is 80c away... for the bears the sky is the limit if the FDA approves... potential bloodbath for the bears 🐻

$INO We have a Market Cap of $100M and just won the lawsuit for $80M! That’s crazy! Release the news! 🎉🚀🔥

$INO Unshackled. Finally. The chains are off. This day has to be the most cathartic in years. Worried about collecting the judgement? Don’t be. There is no way the lawyers stayed with this so long unless there was a reason. And it turns out they now have 18 million reasons. Inovio won’t have to lift a finger. The value of the company instantly increases. Dramatically so. And then, oh yeah, there is October 30. Judgement day cometh. You know where I stand. Because it’s where I’ve always stood. And that is on the cusp of the DNA revolution. Not that I had anything to do with it. But we all participate through our vicarious ownership of company shares. This is happening. And we are going ballistic. Book it. imho xx

$INO While mRNA pullbacks reveal LNP limits in chronic therapies due to toxicity, plasmid DNA with electroporation (Cellectra) offers 40 years of clean science. No viral vectors, no synthetic lipids—just safe, unlimited redosing. With the FDA reviewing INO-3107 (86% surgery reduction in RRP), the shift to proven, long-term safety standards is here. DNA is ready to claim its place. We are on the verge of achieving it!

$INO Big pharma doesn’t want DNA plasmid medicines to happen. It will upset their sales model. But guess what, they can’t stop the science. It’s happening. INO-3107 soon here in the USA, then on to Europe. Also with VGX-3100 across China. Asking for a friend, how many women are in China? And don’t forget that PLS-D1000 has already been approved for senior dogs from Plumbline Life Sciences.

$INO Absolutely do not let anyone talk you out of your shares. 6.5 year lawsuit won. $80 million dollar decision made on behalf of Inovio. Who cares about collection. We won. Next stop fda Pdufa

$INO Preparing for a big run! Hold on to your shares! Either news of the lawsuit we just won or the FDA approval will see us running hard!! let’s go! 🚀🚀🚀

$INO The heavy volume after hours indicates to me that NO 3107 news has leaked. GLT Longs. The 80 million dollar judgement is nice, but the catalysts in the near term are far more important: 3107, 5401, 3100, Ebola, Hepatitis, HIV, DMABs, and others..........Stay Tuned: "First the contribution, then the reward."

$INO We are entering the most important stretch in INOVIO’s history. The FDA has completed its major review meetings and inspections, INOVIO has presented its case for accelerated approval, and the company is preparing for a potential launch. The October 30 PDUFA date is almost here. FDA and INOVIO are working through the final regulatory details, including the confirmatory trial design and the label. If the FDA is comfortable with the totality of the data and agrees that INO-3107 provides a meaningful benefit for RRP patients, we could see approval before the official deadline. Approval with a post approval confirmatory trial would be a major win for INOVIO, because it would allow the company to move toward commercialization while continuing to generate additional data. My view is that the next two weeks will be a defining moment for INOVIO and potentially the beginning of an entirely new chapter for the company. Good luck to all the investors out there.